InVivo Therapeutics announced the inclusion of data from the Christopher & Dana Reeve Foundation North American Clinical Trials Network Registry in its Contemporary Thoracic SCI Registry Study, a complement to the ongoing study of the company's Neuro-Spinal Scaffold. A protocol has already been submitted by the company to the FDA for the CONTEMPO Registry Study, which is intended to provide natural history benchmarks for results of the scaffold study.
Update to CONTEMPO Registry Study announced by InVivo Therapeutics
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.